| RS2493290372 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493292629 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS2493292694 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493293194 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493294655 |
COL17A1
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1A, Amelogenesis imperfecta type 1A |
| RS2493294749 |
COL17A1
|
Health Risk |
Likely pathogenic |
Epithelial recurrent erosion dystrophy, Epithelial recurrent erosion dystrophy |
| RS2493296322 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS2493298308 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS2493298472 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493300850 |
COL17A1
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa, junctional 4 |
| RS2493301375 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS2493306888 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493307013 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493307221 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493307366 |
COL17A1
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1A, Amelogenesis imperfecta type 1A |
| RS2493308471 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS2493312925 |
COL17A1
|
Health Risk |
Likely pathogenic |
Epithelial recurrent erosion dystrophy, Epidermolysis bullosa |
| RS2493318777 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS2493318808 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493326161 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493327043 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS2493327107 |
COL17A1
|
Health Risk |
Likely pathogenic |
COL17A1-related disorder, COL17A1-related disorder |
| RS2493333188 |
COL17A1
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1A, Amelogenesis imperfecta type 1A |
| RS2493335169 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493336185 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2493336259 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2493336379 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2493336930 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2493337844 |
ASCC1
|
Health Risk |
Likely pathogenic |
ASCC1-related disorder, ASCC1-related disorder |
| RS2493338396 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2493339279 |
COL17A1
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, Amelogenesis imperfecta |
| RS2493340659 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493355998 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493359669 |
ANK3
|
Health Risk |
Likely pathogenic |
— |
| RS2493360895 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493361251 |
SLF2
|
Health Risk |
Pathogenic |
Atelis syndrome 1, Atelis syndrome 1 |
| RS2493362837 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS2493375084 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS2493375263 |
COL17A1
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1A, Amelogenesis imperfecta type 1A |
| RS2493375635 |
COL17A1
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS2493375701 |
CNNM2
|
Health Risk |
Likely pathogenic |
— |
| RS2493375718 |
CNNM2
|
Health Risk |
Likely pathogenic |
Hypomagnesemia, seizures |
| RS2493375756 |
CNNM2
|
Health Risk |
Likely pathogenic |
Renal hypomagnesemia 6, Renal hypomagnesemia 6 |
| RS2493376631 |
CNNM2
|
Health Risk |
Pathogenic |
Renal hypomagnesemia 6, Renal hypomagnesemia 6 |
| RS2493376669 |
CNNM2
|
Health Risk |
Pathogenic |
Renal hypomagnesemia 6, Renal hypomagnesemia 6 |
| RS2493377590 |
CNNM2
|
Health Risk |
Pathogenic |
— |
| RS2493381641 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493386649 |
SLF2
|
Health Risk |
Pathogenic |
Atelis syndrome 1, Atelis syndrome 1 |
| RS2493387507 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493391411 |
WDR11
|
Health Risk |
Likely pathogenic |
— |
| RS2493395710 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS2493395783 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2493409912 |
RBM20
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2493410173 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1DD |
| RS2493410346 |
RBM20
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2493412604 |
RBM20
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2493412774 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS2493412820 |
RBM20
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2493413225 |
RBM20
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2493413630 |
CPN1
|
Health Risk |
Pathogenic |
Anaphylotoxin inactivator deficiency, Anaphylotoxin inactivator deficiency |
| RS2493417684 |
RBM20
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2493419778 |
SLF2
|
Health Risk |
Pathogenic |
Atelis syndrome 1, Atelis syndrome 1 |
| RS2493421291 |
RBM20
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2493422751 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2493422939 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1DD |
| RS2493443432 |
VAX1
|
Health Risk |
Likely pathogenic |
Microphthalmia, Microphthalmia |
| RS2493449411 |
RBM20
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2493463036 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2493463533 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2493464596 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2493472668 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1DD |
| RS2493472844 |
RBM20
|
Health Risk |
Pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2493473672 |
RBM20
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2493473776 |
RBM20
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2493475607 |
RBM20
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS2493481426 |
NKX6-2
|
Health Risk |
Likely pathogenic |
Spastic ataxia 8, autosomal recessive |
| RS2493481557 |
NKX6-2
|
Health Risk |
Likely pathogenic |
— |
| RS2493481752 |
PRF1
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493481876 |
PRF1
|
Health Risk |
Likely pathogenic |
Aplastic anemia, Aplastic anemia |
| RS2493482240 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493482339 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493482360 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493482370 |
PRF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Aplastic anemia |
| RS2493482475 |
PRF1
|
Health Risk |
Likely pathogenic |
Aplastic anemia, Aplastic anemia |
| RS2493482798 |
PRF1
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493482848 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Aplastic anemia |
| RS2493482963 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493483138 |
PRF1
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis, Familial hemophagocytic lymphohistiocytosis |
| RS2493483298 |
PRF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aplastic anemia, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493483315 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493483759 |
PRF1
|
Health Risk |
Likely pathogenic |
Aplastic anemia, Aplastic anemia |
| RS2493484050 |
PRF1
|
Health Risk |
Pathogenic |
Aplastic anemia, Familial hemophagocytic lymphohistiocytosis |
| RS2493484211 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493484253 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493484321 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493484435 |
PRF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Aplastic anemia, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493484953 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS2493485105 |
PRF1
|
Health Risk |
Likely pathogenic |
Aplastic anemia, Aplastic anemia |
| RS2493485118 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2493485428 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |